PNV-Select

NDC 42192-320 · Acella Pharmaceuticals, LLC

Generic nameVITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, ALPHA-TOCOPHEROL ACETATE, DL, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, BIOTIN, CALCIUM PANTOTHENATE, CALCIUM CARBONATE, FERROUS FUMARATE, POTASSIUM IODIDE, MAGNESIUM OXIDE, ZINC OXIDE and CUPRIC OXIDE

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, BIOTIN, CALCIUM PANTOTHENATE, CALCIUM CARBONATE, FERROUS FUMARATE, POTASSIUM IODIDE, MAGNESIUM OXIDE, ZINC OXIDE, CUPRIC OXIDE

Strength10; 80; 300; 120; 6; 400; 2; 12; 27; 1; 30; 20; 150; 20; 3.4; 3; 2500; 15 [iU]/1; mg/1; ug/1; mg/1; mg/1; [iU]/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; mg/1; [iU]/1; ug/1

Pharmacologic classAnalogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]

Marketing categoryUNAPPROVED DRUG OTHER

Packages

42192-320-90 — 90 TABLET, FILM COATED in 1 BOTTLE (42192-320-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

41415-111 — Calcium Carbonate, 41415-201 — Calcium carbonate, 41415-296 — Calcium Carbonate, 41415-400 — Zinc Acetate and Pramoxine Hydrochloride, 41415-420 — Zinc Acetate and Pramoxine Hydrochloride, 41520-031 — calcium carbonate, 41520-409 — famotidine, calcium carbonate and magnesium hydroxide, 41520-617 — Famotidine, Calcium Carbonate, Magnesium Hydroxide, 41520-905 — Calcium carbonate, 42192-301 — folic acid, pyridoxine hydrochloride, cyanocobalamin, omega-3 fatty acids, doconexent, icosapent and .beta.-sitosterol, 42192-321 — ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, cyanocobalamin, calcium, ferrous fumarate,…, 42192-323 — ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, calcium, ferrous fumarate, doconexent, 42192-332 — ascorbic acid, cholecalciferol, .alpha.-tocopherol, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium corbonate, ferrous…, 42192-374 — Nicotinamide, 42221-127 — Homosalate, Zinc Oxide, 42485-005 — TITANIUM DIOXIDE, ZINC OXIDE, 42507-151 — Calcium carbonate, 42507-171 — Calcium carbonate, 42507-195 — Calcium carbonate, 42507-321 — famotidine, calcium carbonate and magnesium hydroxide, +5925 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels